Iranian Scientists Develop Special Platform for Precise Delivery of Therapeutic Cells to Tumor
“In this project, our focus is on developing a system that can deliver therapeutic cells to the exact location of the tumor in an optimal and controlled manner. This technology can be a turning point in more effective cancer treatment using regenerative medicine,” said Fatemeh Zehtabi, a member of the executive team of this project.
“I previously worked in the field of vascular diseases and cancer in the US, and the idea of designing such a platform was formed from those experiences,” she added.
Zehtabi explained that after returning to Iran, she tried to put this idea in the implementation and commercialization phase in cooperation with a knowledge-based company.
In a relevant development in June, a group of Iranian experts had also succeeded in producing and commercializing devices for making drug-delivery nanocarriers.
The device for processing and generating drug-delivery nanocarriers has been produced in two classes, desktop and industrial, and is used to produce a wide range of drug nanocarriers by using microfluidic technology.
Using these devices, various types of nanoparticles containing drugs or nutrients can be transferred intelligently and purposefully to parts of the patient's body that require these products.
In addition to transferring the active ingredient of the drug to a specific part or parts of the patient's body, these nanocarriers are also used in the production of vaccines, chemotherapy drugs, nutritional supplements, and skin care products.
4155/v
